US Stock MarketDetailed Quotes

AMIX Autonomix Medical

Watchlist
  • 3.190
  • +0.040+1.27%
Close Dec 13 16:00 ET
  • 3.190
  • 0.0000.00%
Post 20:01 ET
6.51MMarket Cap-0.26P/E (TTM)

Autonomix Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-39.51%-1.6M
-180.18%-1.85M
-258.58%-6.65M
-268.87%-2.29M
-2.56M
-1.14M
-661K
-1.85M
-620K
Net income from continuing operations
53.53%-2.81M
-212.02%-2.7M
-675.18%-15.43M
-723.14%-5.41M
---3.11M
---6.04M
---865K
---1.99M
---657K
Operating gains losses
----
----
--8M
--3.03M
--178K
----
----
----
----
Depreciation and amortization
--45K
--43K
--81K
--46K
--35K
--0
--0
--0
--0
Change In working capital
1,315.69%620K
117.65%444K
-41.91%79K
-656.76%-206K
--132K
---51K
--204K
--136K
--37K
-Change in payables and accrued expense
3,892.31%493K
-106.11%-14K
338.58%557K
-627.03%-195K
--536K
---13K
--229K
--127K
--37K
-Change in other current assets
434.21%127K
1,932.00%458K
-5,411.11%-478K
---11K
---404K
---38K
---25K
--9K
--0
Cash from discontinued investing activities
Operating cash flow
-39.51%-1.6M
-180.18%-1.85M
-258.58%-6.65M
-268.87%-2.29M
---2.56M
---1.14M
---661K
---1.85M
---620K
Investing cash flow
Cash flow from continuing investing activities
0
-5K
-19K
-3K
-16K
0
0
0
0
Net PPE purchase and sale
--0
---5K
---19K
---3K
---16K
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
---5K
---19K
---3K
---16K
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
0
0
2,034.81%14.41M
1,334.07%9.68M
1.65M
350K
2.74M
675K
675K
Net issuance payments of debt
----
----
--2M
--0
--1.65M
----
----
--0
--0
Net common stock issuance
--0
--0
1,930.52%13.71M
1,509.78%10.87M
--0
--0
--2.84M
--675K
--675K
Net other financing activities
----
----
---1.3M
---1.19M
---5K
--0
---105K
----
----
Cash from discontinued financing activities
Financing cash flow
--0
--0
2,034.81%14.41M
1,334.07%9.68M
--1.65M
--350K
--2.74M
--675K
--675K
Net cash flow
Beginning cash position
129.70%6.75M
895.14%8.61M
-57.68%865K
50.37%1.22M
--2.15M
--2.94M
--865K
--2.04M
--810K
Current changes in cash
-101.01%-1.6M
-189.54%-1.86M
756.74%7.74M
13,336.36%7.39M
---927K
---794K
--2.07M
---1.18M
--55K
End cash Position
140.33%5.16M
129.70%6.75M
895.14%8.61M
895.14%8.61M
--1.22M
--2.15M
--2.94M
--865K
--865K
Free cash flow
-39.51%-1.6M
-180.94%-1.86M
-259.60%-6.67M
-269.35%-2.29M
---2.57M
---1.14M
---661K
---1.85M
---620K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q2)Sep 30, 2024 (Q1)Jun 30, 2024 (FY)Mar 31, 2024 (Q4)Mar 31, 2024 (Q3)Dec 31, 2023 (Q2)Sep 30, 2023 (Q1)Jun 30, 2023 (FY)Mar 31, 2023 (Q4)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -39.51%-1.6M -180.18%-1.85M -258.58%-6.65M -268.87%-2.29M -2.56M -1.14M -661K -1.85M -620K
Net income from continuing operations 53.53%-2.81M -212.02%-2.7M -675.18%-15.43M -723.14%-5.41M ---3.11M ---6.04M ---865K ---1.99M ---657K
Operating gains losses ---- ---- --8M --3.03M --178K ---- ---- ---- ----
Depreciation and amortization --45K --43K --81K --46K --35K --0 --0 --0 --0
Change In working capital 1,315.69%620K 117.65%444K -41.91%79K -656.76%-206K --132K ---51K --204K --136K --37K
-Change in payables and accrued expense 3,892.31%493K -106.11%-14K 338.58%557K -627.03%-195K --536K ---13K --229K --127K --37K
-Change in other current assets 434.21%127K 1,932.00%458K -5,411.11%-478K ---11K ---404K ---38K ---25K --9K --0
Cash from discontinued investing activities
Operating cash flow -39.51%-1.6M -180.18%-1.85M -258.58%-6.65M -268.87%-2.29M ---2.56M ---1.14M ---661K ---1.85M ---620K
Investing cash flow
Cash flow from continuing investing activities 0 -5K -19K -3K -16K 0 0 0 0
Net PPE purchase and sale --0 ---5K ---19K ---3K ---16K --0 --0 --0 --0
Cash from discontinued investing activities
Investing cash flow --0 ---5K ---19K ---3K ---16K --0 --0 --0 --0
Financing cash flow
Cash flow from continuing financing activities 0 0 2,034.81%14.41M 1,334.07%9.68M 1.65M 350K 2.74M 675K 675K
Net issuance payments of debt ---- ---- --2M --0 --1.65M ---- ---- --0 --0
Net common stock issuance --0 --0 1,930.52%13.71M 1,509.78%10.87M --0 --0 --2.84M --675K --675K
Net other financing activities ---- ---- ---1.3M ---1.19M ---5K --0 ---105K ---- ----
Cash from discontinued financing activities
Financing cash flow --0 --0 2,034.81%14.41M 1,334.07%9.68M --1.65M --350K --2.74M --675K --675K
Net cash flow
Beginning cash position 129.70%6.75M 895.14%8.61M -57.68%865K 50.37%1.22M --2.15M --2.94M --865K --2.04M --810K
Current changes in cash -101.01%-1.6M -189.54%-1.86M 756.74%7.74M 13,336.36%7.39M ---927K ---794K --2.07M ---1.18M --55K
End cash Position 140.33%5.16M 129.70%6.75M 895.14%8.61M 895.14%8.61M --1.22M --2.15M --2.94M --865K --865K
Free cash flow -39.51%-1.6M -180.94%-1.86M -259.60%-6.67M -269.35%-2.29M ---2.57M ---1.14M ---661K ---1.85M ---620K
Currency Unit USD USD USD USD USD USD USD USD USD
Audit Opinions -- -- Unqualified Opinion with Explanatory Notes -- -- -- -- -- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.